サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485955

デング熱検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、エンドユーザー別、地域別

Dengue Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

出版日
ページ情報
英文 240 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デング熱検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、エンドユーザー別、地域別
出版日: 2024年05月22日
発行: Fairfield Market Research
ページ情報: 英文 240 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

デング熱の世界の罹患率は急速に増加しており、アフリカ、南北アメリカ、東地中海、東南アジア、西太平洋などの主要地域で大きな影響を及ぼしています。世界保健機関（WHO）は、デング熱患者の継続的な増加を報告しており、効果的な診断ソリューションの緊急の必要性を強調しています。

南北アメリカでは、デング熱の流行が憂慮すべきレベルに達しており、数100万人の患者が報告されています。ブラジルがホットスポットとして浮上し、これらの症例のかなりの部分を占めています。ブラジルにおけるデング熱感染者の急増は、健康危機の深刻化を浮き彫りにしており、以前の数値と比較して大幅に増加しています。

西太平洋地域でも、デング熱が疑われる症例が相当数発生しています。フィリピンとマレーシアは最も影響を受けている国のひとつであり、いずれも高い症例数を報告しています。これらの地域ではデングウイルスの流行が拡大しており、タイムリーで正確な検知に不可欠な診断キットの需要が高まっています。

気候変動は、世界中でデング熱の流行を悪化させています。デング熱、チクングニア、ウエストナイルウイルスが、これまで影響を受けていなかった国々で最近発生したことは、地球温暖化がもたらす潜在的な脅威を浮き彫りにしています。気候の変化は、欧州を含む様々な地域における現在および将来のリスクを高めており、媒介蚊の分布や潜在的な疾病伝播に大きな影響を与えています。

当レポートでは、世界のデング熱検査市場について調査し、市場の概要とともに、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • 経済概要
  • PESTLE分析

第3章 世界のデング熱検査市場の見通し、2018年～2031年

  • 世界のデング熱検査市場の見通し、製品タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界のデング熱検査市場の見通し、エンドユーザー別、金額（10億米ドル）、2018年～2031年
  • 世界のデング熱検査市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米のデング熱検査市場の見通し、2018年～2031年

第5章 欧州のデング熱検査市場の見通し、2018年～2031年

第6章 アジア太平洋のデング熱検査市場の見通し、2018年～2031年

第7章 ラテンアメリカのデング熱検査市場の見通し、2018年～2031年

第8章 中東・アフリカのデング熱検査市場の見通し、2018年～2031年

第9章 競合情勢

  • 製品別とエンドユーザー別のヒートマップ
  • 企業市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Roche Molecular Systems Inc.
    • Abbott Laboratories
    • InBios International, Inc.
    • NovaTec Immundiagnostica GmbH
    • Quest Diagnostics
    • Certest Biotec S.L.
    • OriGene Technologies
    • Abnova Corporation
    • その他

第10章 付録

目次

The global incidence of dengue has been increasing rapidly, with significant impacts across major regions including Africa, the Americas, the Eastern Mediterranean, Southeast Asia, and the Western Pacific. The World Health Organization (WHO) reports a continuous rise in dengue cases, highlighting the urgent need for effective diagnostic solutions.

Rising Dengue Cases Across the Globe

Americas

In the Americas, the prevalence of dengue has reached alarming levels, with millions of reported cases. Brazil has emerged as a hotspot, contributing a substantial portion of these cases. The surge in dengue cases in Brazil underscores the growing health crisis, with a significant increase compared to previous figures.

Western Pacific Region

The Western Pacific region has also witnessed a significant number of suspected dengue cases. The Philippines and Malaysia are among the most affected countries, both reporting high case numbers. This escalating prevalence of the dengue virus in these regions is driving the demand for diagnostic kits, crucial for timely and accurate detection.

Climate Change and Dengue Fever

Impact of Climate Change

Climate change is exacerbating the prevalence of dengue fever worldwide. Recent outbreaks of dengue, chikungunya, and West Nile virus in previously unaffected countries highlight the potential threats posed by global warming. Changes in climate have heightened current and future risks in various regions, including Europe, significantly impacting vector distribution and potential disease transmission.

Environmental Factors

Environmental factors such as high rainfall and humidity create favorable breeding conditions for mosquitoes. Additionally, curtailed water supply and disrupted sanitation services facilitate mosquito proliferation, while warm temperatures extend the active season for these vectors. These climatic changes are likely to increase the burden of dengue fever, subsequently driving the growth of the dengue testing market.

Innovations in Dengue Testing

Need for Cost-Effective Diagnostic Kits

Currently, the available diagnostic test kits for dengue are less effective, creating a need for cost-effective kits with high specificity and sensitivity. The high price and limited effectiveness of existing test kits have prompted companies to focus on developing reliable and affordable diagnostic methods. Increasing research and development activities aim to produce highly specific and sensitive diagnostic kits, opening new growth opportunities for manufacturers.

Development of Point-of-Care Tests

Manufacturers are prioritizing the development of point-of-care tests that are rapid, sensitive, and easy to use. Many existing methods for detecting the dengue virus rely on cell culture and mice inoculation, which are slow and expensive. There is a pressing need for rapid, user-friendly, and sensitive detection methods to enhance the efficiency of dengue diagnosis.

Global Dengue Testing Market by Region

Dominance of Asia Pacific

The Asia Pacific region has been at the forefront of the global dengue testing market in terms of revenue. This trend is expected to continue, with Asia Pacific projected to remain the most attractive market for dengue testing. The region's significant share in the global dengue testing market underscores its critical role in addressing the dengue epidemic.

Key Market Players Include:

  • Abnova Corporation
  • Roche Molecular Systems Inc.
  • Abbott Laboratories
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Euroimmun AG (Sub. PerkinElmer)
  • Quest Diagnostics
  • Certest Biotec S.L.
  • OriGene Technologies
  • Thermo Fisher Scientific Inc.
  • Others.

Global Dengue Testing Market Segmentation:

By Product Type:

  • Premium
  • Mid
  • Low

By End User:

  • Hospitals
  • Public Health Laboratory
  • Diagnostic Centers
  • Others

By Region:

  • China
  • India
  • Japan
  • Indonesia
  • South Korea
  • Rest of Asia Pacific

Table of Contents

1. Executive Summary

  • 1.1. Global Dengue Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. Global Dengue Testing Market Outlook, 2018 - 2031

  • 3.1. Global Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. ELISA-based Tests
      • 3.1.1.2. RT-PCR based Tests
      • 3.1.1.3. Dengue IgG/IgM Rapid Test
  • 3.2. Global Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Public Health Laboratory
      • 3.2.1.3. Diagnostic Centers
      • 3.2.1.4. Others
  • 3.3. Global Dengue Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Dengue Testing Market Outlook, 2018 - 2031

  • 4.1. North America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. ELISA-based Tests
      • 4.1.1.2. RT-PCR based Tests
      • 4.1.1.3. Dengue IgG/IgM Rapid Test
  • 4.2. North America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Public Health Laboratory
      • 4.2.1.3. Diagnostic Centers
      • 4.2.1.4. Others
  • 4.3. North America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Dengue Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. ELISA-based Tests
      • 5.1.1.2. RT-PCR based Tests
      • 5.1.1.3. Dengue IgG/IgM Rapid Test
  • 5.2. Europe Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Public Health Laboratory
      • 5.2.1.3. Diagnostic Centers
      • 5.2.1.4. Others
  • 5.3. Europe Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Dengue Testing Market by Product Type, Value (US$Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dengue Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. ELISA-based Tests
      • 6.1.1.2. RT-PCR based Tests
      • 6.1.1.3. Dengue IgG/IgM Rapid Test
  • 6.2. Asia Pacific Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Public Health Laboratory
      • 6.2.1.3. Diagnostic Centers
      • 6.2.1.4. Others
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dengue Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. ELISA-based Tests
      • 7.1.1.2. RT-PCR based Tests
      • 7.1.1.3. Dengue IgG/IgM Rapid Test
  • 7.2. Latin America Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Public Health Laboratory
      • 7.2.1.3. Diagnostic Centers
      • 7.2.1.4. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dengue Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Dengue Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. ELISA-based Tests
      • 8.1.1.2. RT-PCR based Tests
      • 8.1.1.3. Dengue IgG/IgM Rapid Test
  • 8.2. Middle East & Africa Dengue Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Public Health Laboratory
      • 8.2.1.3. Diagnostic Centers
      • 8.2.1.4. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Dengue Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Dengue Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Dengue Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Product vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Therapy Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Roche Molecular Systems Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Therapy Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Abbott Laboratories
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Therapy Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. InBios International, Inc.
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Therapy Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. NovaTec Immundiagnostica GmbH
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Therapy Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Quest Diagnostics
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Therapy Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Certest Biotec S.L.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Therapy Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. OriGene Technologies
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Therapy Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Abnova Corporation
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Therapy Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Others
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Therapy Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1.Research Methodology
  • 10.2.Report Assumptions
  • 10.3.Acronyms and Abbreviations